Working...
ClinicalTrials.gov
ClinicalTrials.gov Menu
Trial record 25 of 640 for:    Russian Federation | Chile

ENHANCE: Seladelpar in Subjects With Primary Biliary Cholangitis (PBC) and an Inadequate Response to or an Intolerance to Ursodeoxycholic Acid (UDCA)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT03602560
Recruitment Status : Recruiting
First Posted : July 27, 2018
Last Update Posted : August 20, 2019
Sponsor:
Information provided by (Responsible Party):
CymaBay Therapeutics, Inc.

No Study Results Posted on ClinicalTrials.gov for this Study
  Recruitment Status : Recruiting
  Estimated Primary Completion Date : December 2020
  Estimated Study Completion Date : December 2021